Targeting Molecular Signals in Chk1 Pathways as a New Approach for Overcoming Drug Resistance

Author： Hapke G.   Yin M-b.   Rustum Y.M.  

Publisher： Springer Publishing Company

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.20, Iss.1-2, 2001-03, pp. : 111-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the ATR-CHK1 Axis in Cancer Therapy

By Rundle Stuart   Bradbury Alice   Drew Yvette   Curtin Nicola J.  

Cancers, Vol. 9, Iss. 5, 2017-04 ,pp. : 41-41

MDPI

Access to resources Recommend Favorite

New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways

By  

Current Cancer Therapy Reviews, Vol. 11, Iss. 4, 2015-12 ,pp. : 222-259

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux

By Lin Fan   de Gooijer Mark C   Hanekamp Diana   Brandsma Dieta   Beijnen Jos H   van Tellingen Olaf  

CNS Oncology, Vol. 2, Iss. 3, 2013-05 ,pp. : 271-288

Future Medicine

Access to resources Recommend Favorite

MicroRNA197 reverses the drug resistance of fluorouracilinduced SGC7901 cells by targeting mitogenactivated protein kinase 1

By            

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5019-5025

Spandidos Publications

Access to resources Recommend Favorite

Overcoming Chronic Myeloid Leukemia Stem Cell Resistance to Imatinib by Also Targeting JAK2

By Cogle Christopher R.  

Journal of the National Cancer Institute, Vol. 105, Iss. 6, 2013-03 ,pp. : 378-379

Oxford University Press

Access to resources Recommend Favorite